Ann Intern Med:美更新成人腹主动脉瘤筛查建议

2014-07-03 cath 编译 医学论坛网

美国预防服务工作组(USPSTF)于近日更新了关于腹主动脉瘤筛查的推荐建议。全文6月24日在线发表于《内科学文献》(Ann Intern Med)。 这些推荐适用于无症状的年龄≥50岁的成人。具体内容如下。 1、 对有吸烟史的、年龄65—75岁的男性,推荐用超声筛查一次AAA(B级推荐)。 2、 对从不吸烟的、年龄65—75岁的男性,推荐临床医生选择性提供AAA的筛查

美国预防服务工作组(USPSTF)于近日更新了关于腹主动脉瘤筛查的推荐建议。全文6月24日在线发表于《内科学文献》(Ann Intern Med)。

这些推荐适用于无症状的年龄≥50岁的成人。具体内容如下。

1、 对有吸烟史的、年龄65—75岁的男性,推荐用超声筛查一次AAA(B级推荐)。

2、 对从不吸烟的、年龄65—75岁的男性,推荐临床医生选择性提供AAA的筛查(C级推荐)。

3、 当前证据不足以评估有吸烟史、年龄65—75岁的女性筛查AAA的获益与风险(I级声明)。

4、 反对从未吸烟女性常规筛查AAA(D级推荐)。

查看链接:

Screening for Abdominal Aortic Aneurysm

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1414976, encodeId=88e914149e659, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428989, encodeId=4f3414289892a, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606231, encodeId=d353160623194, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1414976, encodeId=88e914149e659, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428989, encodeId=4f3414289892a, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606231, encodeId=d353160623194, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1414976, encodeId=88e914149e659, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1428989, encodeId=4f3414289892a, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606231, encodeId=d353160623194, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 05 06:33:00 CST 2014, time=2014-07-05, status=1, ipAttribution=)]